Livanova Plc Quick Ratio (LIVN) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Livanova Plc  (NASDAQ: LIVN)

Livanova Plc's Quick Ratio

LIVN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Livanova Plc's Cash & cash equivalent grew by 9.07 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Livanova Plc's Quick Ratio to 0.76, Quick Ratio remained below Livanova Plc average.

Within Medical Equipment & Supplies industry 127 other companies have achieved higher Quick Ratio than Livanova Plc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1358 to 2246.

Explain Quick Ratio?
How much Cash & cash equivalents LIVN´s has?
What are LIVN´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/LIVN/financial-strength
https://api.csimarket.com/api/v1/companies/LIVN/fundamentals
https://api.csimarket.com/api/v1/companies/LIVN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
LIVN Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change -10.56 %
Y / Y Cash & cash equivalent Change -12.79 %
Quick Ratio MRQ 0.76
LIVN's Total Ranking # 2246
Seq. Current Liabilities Change 4.69 %
Seq. Cash & cash equivalent Change 9.07 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 687
Overall Market # 2246


Quick Ratio Statistics
High Average Low
14.59 1.27 0.07
(Apr 26 2013)   (Jun 30 2019)




Financial Statements
Livanova Plc's Current Liabilities $ 740 Millions Visit LIVN's Balance sheet
Livanova Plc's Cash & cash equivalent $ 563 Millions Visit LIVN's Balance sheet
Source of LIVN's Sales Visit LIVN's Sales by Geography


Cumulative Livanova Plc's Quick Ratio

LIVN's Quick Ratio for the trailling 12 Months

LIVN Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 25.87 %
Y / Y Cash & cash equivalent TTM Growth -16.52 %
Quick Ratio TTM 0.75
Total Ranking TTM # 3993
Seq. Current Liabilities TTM Growth -2.81 %
Seq. Cash & cash equivalent TTM Growth -3.53 %


On the trailing twelve months basis In spite of the year on year decrease in LIVN's Current Liabilities to $740.19 millions, cumulative Quick Ratio to 0.75 below the LIVN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Livanova Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3169 to 3993.

Explain Quick Ratio?
How much Cash & cash equivalents LIVN´s has?
What are LIVN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 900
Within the Market # 3993


trailing twelve months Quick Ratio Statistics
High Average Low
1.96 0.75 0.09
(Dec 31 2024)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Myomo Inc   0.93 $ 11.946  Millions$ 12.902  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions

Date modified: 2026-11-07T13:22:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.